Aloperine inhibits the progression of non-small-cell lung cancer through the PI3K/Akt signaling pathway

Fujuan Liu(Linyi People's Hospital), Haiying Li(Qilu Hospital of Shandong University)
Cancer Cell International
December 1, 2021
Cited by 9


Related Papers